Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
The Team
Advisors
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Biomarker Capture Platform
SubB2M Pan-Cancer Probe
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Business Development
Products
Our Products
hTERT ICC Test
EXO-NET® Pan-Exosome
Product Technology & Features
Workflow and Performance
Product Ordering
Resources
Pipeline
Development Pipeline
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
Conferences & Events
Media
INOVIQ in the News
Contact
Contact Us
Subscribe to Email Alerts
Partners
Heading &
Sub-heading can be edited through HQI
About Us
>
Partners
About INOVIQ
Market Opportunity
Board
The Team
Advisors
Partners
Distributors
Compliance
Careers
Partners
Griffith University Mucosal Immunology Research Group
Contract research services for development and validation of INOVIQ autoantibody tests.
Griffith University Institute for Glycomics
Collaborative Research Agreement for development of SubB2M pan-cancer probe assays for detection of a range of cancers.
Thermo Fisher Scientific
Assay development agreement for Research Use Only (RUO) INOVIQ kits for detection of INOVIQ autoantibodies using the Luminex.
University of Geneva
Collaborative research agreement and contract research services for research of INOVIQ biomarkers for ovarian, breast and lung cancer detection.
University of QLD – UniQuest
Collaborative Research Agreement evaluating the effectiveness of EXO-NET™ for the purification of exosomes containing certain cancer markers.
University of Sydney
Collaborative Research Agreement evaluating the effectiveness of EXO-NET™ for the purification of exosomes containing certain cancer markers